InvestorsHub Logo
Followers 0
Posts 47
Boards Moderated 0
Alias Born 06/16/2015

Re: None

Saturday, 08/08/2020 10:03:11 PM

Saturday, August 08, 2020 10:03:11 PM

Post# of 14947
Big news coming in arbitration case In case you missed this post:

Here is some information and an opinion on the PSS lawsuit .

Case 19STCV11328 arbitration in the case of Sorrento v NantPharma is ongoing.. with a status hearing on 8/12. Pending arbitration must be settled before the consolidated case 20STCV08789 Sorrento v Patrick Soon Shiong for common law fraud will be heard. Consolidated case has been assigned a hearing date of 2/17/2022. Sorrento at its option can pursue a jury trial against PSS under 20STCV08789 if arbitration doesn't resolve by the February hearing date.

Here is another posters analysis

"I'm wishing I can attend the trial. What's Shiong gonna say? That he was a "babe in the woods" and thought Sorrento's Cynvilocq was "good" but it turned out to be "bad"? Really? The inventor of Abraxane, a world class expert on that type of drug, had no clue about what he was buying into???!!!

Not to mention that now-patent-UNprotected Cynvilcq (due to Shiong having allowed patents to expire) is being sold in South Korea and is well known to be a safe and efficacious cancer drug?

Seems like the Shiong legal team will have to pull a rabbit out of a hat to have a chance in this litigation.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SRNE News